The National Foundation for Cancer Research (NFCR) has been promoting and facilitating collaboration among scientists from different countries, yet another role played by the organization in its efforts to help defeat the disease. Case in point: Earlier this month NFCR President Dr. Sujuan Ba played the key role in establishing…...
The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the Foundation’s mandate, messages from the…...
FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations ROCKVILLE, MD – A trio of papers co-authored by…...
In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes, “how different molecular subtypes of glioma cells use different strategies…...
The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association for Cancer Research (AACR), which kicks off tomorrow in Chicago and runs through the following four days. One of the most widely anticipated regular gatherings of cancer scientists in the United…...
FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors BETHESDA, MD – In an event this afternoon at the historic Mayflower Hotel in Washington, DC, two funded scientists of the National Foundation…...
President Bill Clinton declared March Colorectal Cancer Awareness Month in 2000, highlighting a disease that represents eight percent of all new cancers diagnosed yearly and, out of the estimated 135,430 people who developed it just last year, caused an estimated 50,260 deaths in the United States alone. As outlined in…...
FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD – The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize…...
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large B cell lymphoma (DLBCL), a…...
Szent-Györgyi Prize Winners: Then & Now The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary contributions and how their discoveries have made possible new…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
